Brief: Amicus Therapeutics Q1 revenue USD 86.3 million
10/05/2023 14:13
May 10 (Reuters) - Amicus Therapeutics Q1 net income USD -52.9 million. * Q1 revenue USD 86.3 million * Outlook FY revenue growth for Galafold (not total co) 12-17%
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates